Joel Rothman
Corporate Officer/Principal chez EQUILLIUM, INC.
Fortune : 87 225 $ au 31/05/2024
Profil
Joel M.
Rothman is currently the Chief Development Officer at Equillium, Inc. He previously worked as the Director-Regional Operations at ICON Clinical Research, Inc. from 1998 to 2004, Vice President at Cytokinetics, Inc. from 2017 to 2018, Vice President-Development Operations at Jazz Pharmaceuticals, Inc., and Vice President at Raptor Pharmaceuticals, Inc. from 2015 to 2017.
Rothman received his undergraduate degree from Albright College and his graduate degree from Massachusetts Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EQUILLIUM, INC.
0,16% | 02/01/2024 | 58 150 ( 0,16% ) | 87 225 $ | 31/05/2024 |
Postes actifs de Joel Rothman
| Sociétés | Poste | Début |
|---|---|---|
| EQUILLIUM, INC. | Corporate Officer/Principal | 01/01/2021 |
Anciens postes connus de Joel Rothman
| Sociétés | Poste | Fin |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 01/09/2018 |
Raptor Pharmaceuticals, Inc.
 Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Corporate Officer/Principal | 01/01/2017 |
ICON Clinical Research, Inc.
 ICON Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research, Inc. provides research and consulting services. It services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. The company was founded by John Climax and Ronan Lambe in 1990 and is headquartered in North Wales, PA | Corporate Officer/Principal | 01/07/2004 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Formation de Joel Rothman
| Albright College | Undergraduate Degree |
| Massachusetts Institute of Technology | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| EQUILLIUM, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
ICON Clinical Research, Inc.
ICON Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research, Inc. provides research and consulting services. It services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. The company was founded by John Climax and Ronan Lambe in 1990 and is headquartered in North Wales, PA | Commercial Services |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Health Technology |
